Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
Clinical trial NCT02802228 · COMPLETED
Trial details
- NCT number
- NCT02802228
- Sponsor
- Cumberland Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-06
- Primary completion
- 2018-07-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.